Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Dr. Viviana De Luca | Biology and Life Sciences | Research fellow at University of Sannio RCOST | Italy

Dr. Viviana De Luca is a distinguished researcher in biological, environmental, and health sciences, recognized for her advanced expertise in enzymology, carbonic anhydrase biology, antimicrobial drug discovery, and translational biomedical research. Her education encompasses advanced doctoral training in biology and environmental and health sciences, earned from leading Italian universities, with research conducted at prominent national research institutes specializing in biosciences, protein biochemistry, and molecular technologies. She has authored 108 documents, received 3,717 citations, and holds a 39 h-index, underscoring her strong scientific influence and consistent contributions to peer-reviewed literature indexed in major international databases such as Scopus.

Citation Metrics (Scopus)

5000

4000

3000

2000

1000

0

Citations
3,717

Documents
108

h-index
39

🟦 Citations        🟥 Documents     🟩 h-index

View Scopus Profile

Featured Publications

Production, crystallographic studies, and functional profiling of γ-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insights – European Journal of Medicinal Chemistry

Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases – Archiv der Pharmazie

Coumarin-Containing Aromatic Sulfonamides With Carbonic Anhydrase Inhibitory Properties Against Human and Fungal Isoforms – Chemical Biology and Drug Design

Eco-Friendly Synthesis of Chitosan–Fatty Acid Nano Micelles and Their Differential Antibacterial Activity Against Escherichia coli and Bacillus subtilis – Journal of Functional Biomaterials

Acetazolamide-Loaded Nanoparticle Based on Modified Hyaluronic Acid as Delivery System to Target Carbonic Anhydrases in Escherichia coli – International Journal of Molecular Sciences

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award

Dr. Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award | Postdoctoral Researcher | Tehran University of Medical Sciences | Iran

Dr. Zeinab Mohsenipour is a distinguished Iranian microbiologist whose scholarly focus and scientific achievements have advanced the field of Medical Bacteriology, particularly in the areas of antimicrobial resistance, bacterial biofilms, and bacteriophage therapy. She earned her Ph.D. in Medical Bacteriology from Tehran University of Medical Sciences, building on her earlier academic foundation with an M.Sc. in Microbiology and a B.A. in Biology from Shahid Bahonar University of Kerman. Throughout her academic and research journey, Dr. Mohsenipour has demonstrated an unwavering commitment to exploring the molecular and clinical mechanisms underlying infectious diseases. Her professional experience encompasses serving as a Research Assistant in the Bacteriology Laboratory at Tehran University of Medical Sciences and as a Lecturer at the University of Science and Culture, where she has taught undergraduate courses in microbial physiology, medical bacteriology, and microbial diversity. Beyond academia, she has also held an industry leadership role as Sales Manager at NojanTeb Azma Company, gaining practical insight into the intersection of scientific innovation and healthcare product development. Her research interests center on the study of antibiotic-resistant pathogens, biofilm inhibition, natural antimicrobial compounds, and the therapeutic application of predatory bacteria and bacteriophages. Dr. Mohsenipour possesses an extensive range of research skills, including bacterial culture and identification, PCR and molecular cloning, antibiotic susceptibility testing, and animal model experimentation, all of which contribute to her capacity for translational biomedical research. Her scientific productivity is evidenced by her numerous peer-reviewed publications in reputable journals indexed in Scopus, Frontiers, and BMC, addressing urgent microbiological issues such as lung infection models and bacterial-based drug delivery systems. Dr. Mohsenipour has also co-authored scientific books that enrich microbiological education, including An Overview of Monoclonal Antibodies: Production Methods and Applications and The Principle of Microbial Physiology. Her contributions have been recognized through invitations to serve as a reviewer for the European Journal of Clinical and Biomedical Sciences and through memberships in esteemed professional societies such as the American Society for Microbiology (ASM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Dr. Mohsenipour’s excellence in both teaching and research reflects her passion for nurturing scientific inquiry and innovation. Her continuous involvement in international collaborations, advanced workshops, and cutting-edge bacteriological projects underscores her role as a promising and impactful researcher who is shaping the future of microbial science and global health improvement.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Mohsenipour, Z., & Hassanshahian, M. (2015). The inhibitory effect of Thymus vulgaris extracts on the planktonic form and biofilm structures of six human pathogenic bacteria. Avicenna Journal of Phytomedicine, 5(4), 309–318. (Citations: 94)

  2. Mohsenipour, Z., & Hassanshahian, M. (2015). The effects of Allium sativum extracts on biofilm formation and activities of six pathogenic bacteria. Jundishapur Journal of Microbiology, 8(8), e18971. (Citations: 78)

  3. Mohsenipour, Z., & Hassanshahian, M. (2016). Antibacterial activity of Euphorbia hebecarpa alcoholic extracts against six human pathogenic bacteria in planktonic and biofilm forms. Jundishapur Journal of Microbiology, 9(6), e34701. (Citations: 63)

  4. Omidinia, E., Shahbazmohammadi, H., & Mohsenipour, Z. (2019). Partitioning of recombinant Pseudomonas putida POS-F84 proline dehydrogenase in aqueous two-phase systems: Optimization using response surface methodology. Applied Biochemistry and Biotechnology, 189, 498–510. (Citations: 32)

  5. Tajabadi, F. H., Karimian, S. M., Mohsenipour, Z., et al. (2022). Biocontrol treatment: Application of Bdellovibrio bacteriovorus HD100 against burn wound infection caused by Pseudomonas aeruginosa in mice. Burns: Journal of the International Society for Burn Injuries. (Citations: 19)

  6. Mohsenipour, Z., Arazi, P., Skurnik, M., et al. (2024). Predation on bacterial pathogens by predatory bacteria of sewage origin: Three days prey-predator interactions. BMC Microbiology, 24, 516. (Citations: 12)

  7. Mohsenipour, Z., Kianian, F., Jahanbin, B., Abtahi, H. R., Ghazanfari, T., Edalatifard, M., Amanpour, S., Skurnik, M., Arazi, P., & Feizabadi, M. M. (2025). Predatory bacteria can intensify lung injury in a multidrug-resistant Acinetobacter baumannii pneumonia model in rat. Frontiers in Microbiology, 16, 1512119. (Citations: 7)